(VIANEWS) – NYSE Composite ended the session with Teva Pharmaceutical jumping 2.62% to $9.01 on Wednesday, after two successive sessions in a row of gains. NYSE Composite jumped 1.08% to $16,497.61, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.
Today’s last reported volume for Teva Pharmaceutical is 10581400, 23.5% above its average volume of 8568100.
Teva Pharmaceutical’s last close was $9.31, 30% below its 52-week high of $13.30.
The company’s growth estimates for the current quarter and the next is 7.3% and 13.8%, respectively.
Teva Pharmaceutical’s Revenue
Year-on-year quarterly revenue growth declined by 8.6%, now sitting on 16.28B for the twelve trailing months.
Teva Pharmaceutical’s Stock Yearly Top and Bottom Value
Teva Pharmaceutical’s stock is valued at $9.01 at 21:01 EST, way below its 52-week high of $13.30 and higher than its 52-week low of $8.24.
Teva Pharmaceutical’s Moving Average
Teva Pharmaceutical’s worth is under its 50-day moving average of $10.01 and way below its 200-day moving average of $10.84.
More news about Teva Pharmaceutical (TEVA).